Gladstone Investment Corporation (0IVR.L)
USD 13.22
(0.11%)
USD 13.22
(0.11%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 63.52 Million USD | -30.29% |
| 2022 | -1.45 Million USD | -55.46% |
| 2021 | 119.5 Million USD | 108.49% |
| 2020 | 24.51 Million USD | 240.47% |
| 2019 | - USD | -76.3% |
| 2018 | 95.09 Million USD | 193.33% |
| 2017 | 24.22 Million USD | 193.83% |
| 2016 | 44.76 Million USD | -78.8% |
| 2015 | - USD | 80.6% |
| 2014 | 21.52 Million USD | 180.98% |
| 2013 | -1.32 Million USD | -568.47% |
| 2012 | -3.97 Million USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | -26.05 Million USD | -100.0% |
| 2023 FY | - USD | 109.92% |
| 2023 Q4 | 29.7 Million USD | 117.01% |
| 2023 Q3 | 13.68 Million USD | -74.67% |
| 2023 Q1 | 14.3 Million USD | 54.28% |
| 2023 Q2 | 54.03 Million USD | 277.73% |
| 2022 Q2 | 7.38 Million USD | -54.62% |
| 2022 Q4 | 9.27 Million USD | -54.34% |
| 2022 FY | - USD | -55.46% |
| 2022 Q1 | 16.26 Million USD | -22.25% |
| 2022 Q3 | 20.3 Million USD | 175.06% |
| 2021 Q1 | 51.39 Million USD | 110.03% |
| 2021 Q4 | 20.92 Million USD | 42.22% |
| 2021 FY | - USD | 108.49% |
| 2021 Q2 | 32.47 Million USD | -36.83% |
| 2021 Q3 | 14.71 Million USD | -54.69% |
| 2020 Q4 | 24.47 Million USD | 372.25% |
| 2020 Q3 | 5.18 Million USD | 465.7% |
| 2020 FY | - USD | 240.47% |
| 2020 Q1 | -7.52 Million USD | 83.38% |
| 2020 Q2 | -1.41 Million USD | 81.17% |
| 2019 Q1 | -6.33 Million USD | -192.15% |
| 2019 Q4 | -45.29 Million USD | -1313.15% |
| 2019 Q3 | 3.73 Million USD | 397.2% |
| 2019 Q2 | 751 Thousand USD | 111.86% |
| 2019 FY | - USD | -76.3% |
| 2018 FY | - USD | 193.33% |
| 2018 Q2 | 30.01 Million USD | 7.56% |
| 2018 Q3 | 6.24 Million USD | -79.19% |
| 2018 Q4 | 6.87 Million USD | 9.96% |
| 2018 Q1 | 27.9 Million USD | 92.93% |
| 2017 Q4 | 14.46 Million USD | 142.68% |
| 2017 Q3 | 5.96 Million USD | 34.44% |
| 2017 FY | - USD | 193.83% |
| 2017 Q2 | 4.43 Million USD | 791.73% |
| 2017 Q1 | -641 Thousand USD | -195.39% |
| 2016 FY | - USD | -78.8% |
| 2016 Q1 | 14.2 Million USD | 0.47% |
| 2016 Q4 | 672 Thousand USD | -68.44% |
| 2016 Q2 | -8.76 Million USD | -161.69% |
| 2016 Q3 | 2.12 Million USD | 124.3% |
| 2015 FY | - USD | 80.6% |
| 2015 Q4 | 14.13 Million USD | 198.4% |
| 2015 Q3 | -14.36 Million USD | -47.19% |
| 2015 Q2 | -9.76 Million USD | -9397.14% |
| 2015 Q1 | 105 Thousand USD | -99.51% |
| 2014 Q1 | 4.2 Million USD | 179.54% |
| 2014 Q2 | -3.22 Million USD | -176.58% |
| 2014 Q3 | -780.99 Thousand USD | 75.75% |
| 2014 Q4 | 21.32 Million USD | 2830.35% |
| 2014 FY | - USD | 180.98% |
| 2013 Q2 | 7.14 Million USD | 159.62% |
| 2013 Q3 | -16.45 Million USD | -330.31% |
| 2013 Q4 | -5.28 Million USD | 67.87% |
| 2013 FY | - USD | -568.47% |
| 2013 Q1 | -11.98 Million USD | -234.18% |
| 2012 FY | - USD | 0.0% |
| 2012 Q3 | -448 Thousand USD | 0.0% |
| 2012 Q4 | 8.93 Million USD | 2093.97% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Ameriprise Financial, Inc. | 3.4 Billion USD | 98.134% |
| Principal Financial Group, Inc. | 1.05 Billion USD | 93.959% |
| Africa Opportunity Fund Limited | -1.29 Million USD | 5012.769% |
| BH Macro Limited | -42.01 Million USD | 251.207% |
| BioPharma Credit PLC | - USD | -Infinity% |
| CATCo Reinsurance Opportunities Fund Ltd. | - USD | -Infinity% |
| Craven House Capital Plc | -5.45 Million USD | 1265.651% |
| JPEL Private Equity Limited | - USD | -Infinity% |
| Pershing Square Holdings, Ltd. | - USD | -Infinity% |
| Ecofin U.S. Renewables Infrastructure Trust PLC | -6.72 Million USD | 1044.935% |
| RTW Venture Fund Limited | - USD | -Infinity% |
| Tufton Oceanic Assets Limited | - USD | -Infinity% |
| Symphony International Holdings Limited | -101.89 Million USD | 162.345% |
| Tetragon Financial Group Limited | - USD | -Infinity% |
| Taylor Maritime Investments Limited | -51.6 Million USD | 223.103% |
| TMT Investments PLC | 6.07 Million USD | -946.321% |
| Third Point Investors Limited | -1.27 Million USD | 5096.241% |